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Abstracts / Osteoarthritis and Cartilage 23 (2015) A17eA25 A23diffusion-weighted imaging. Evaluation of the glycosaminoglycan
(GAG) matrix in cartilage can be done with delayed gadolinium
enhanced MRI of cartilage (dGEMRIC), T1rho relaxation time meas-
urements, sodium MRI, and chemical exchange saturation transfer
(gagCEST). In addition, evaluation of cartilage and other tissues under
load (biomechanics) is also possible with MRI. All of these method have
advantages and drawbacks that may make them more appropriate to a
given imaging situation or study.
Conclusions: A variety of MRI methods to evaluate a joint with osteo-
arthritis are available. The methods of choice in a particular study
depend on many factors, including hardware available, the joint being
studied, and imaging time. Emphasis will be placed on the trade-offs
between the methods and goals of the imaging study. Study of tissue
composition with MRI may be particularly helpful in disease initiation.
Once OA is established, study of tissue morphology with MRI can be
done quantitatively or with semi-quantitative scoring.
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VALUE OF FUTURE EPIDEMIOLOGIC RESEARCH IN OA: THE ART AND
SCIENCE OF SELECTING AN APPROPRIATE STUDY DESIGN
E. Losina. Boston Univ. Sch. of Publ. Hlth., Boston, MA, USA
During the session we will discuss how to optimize the study design
and to ensure it enables researchers to offer a new informative insight
toward the clinical question under study.Wewill discuss how to choose
among several clinical questions to optimize the likely impact of future
research study. We will address the topics of resource prioritization. In
addition the audience will be introduced to the concept of Value of
Information. We will also cover use and misuse several commonly used
statistical methods in analysis of clinical studies in OA.
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CURRENT STATUS OF THE ART IN COMPOSITIONAL IMAGING OF
JOINT TISSUES
T.M. Link. Univ. of California San Francisco, San Francisco, CA, USA
Purpose: To review technologies currently used to assess the bio-
chemical composition of joint tissues and discuss their pros and cons.
Methods available: During the last decade a number of compositional
technologies have been established and studied mostly using quanti-
tative MRI. These include T2 mapping, T1rho, dGEMRIC (delayed
Gadolinium enhanced MRI of the cartilage), Sodium-23-imaging and
gagCEST (glycosaminoglycan chemical exchange saturation transfer)
imaging to quantify cartilage andmeniscal biochemical composition. T2
mapping is currently the most widely used technology and most
information is available on this imaging biomarker, which provides
quantitative data on water content and collagen integrity of the carti-
lage and menisci. According to previous in vitro studies T1rho charac-
terizes the amount of macromolecules within the tissue, which
correlates with the amount of proteoglycans. dGEMRIC requires the
injection of negatively charged Gadolinium contrast agents which
provide quantitative information on the amount of negatively charged
glycosaminoglycans. Both Sodium imaging and gagCEST target the
concentration of glycosaminoglycans, but require imaging at higher
ﬁeld strength. Quantitative CT has also been used in vivo to assess
glycosaminoglycan concentration in hyaline cartilage but it requires the
injection of contrast agents into the joint and there is radiation
exposure.
Results of previous studies: Previous studies showed that imaging
biomarkers of cartilage composition had good reproducibility and
validated these biomarkers both in an in vitro setting and clinically. In
2011 a multi-center ACRIN trial was published which documented that
in a Multi-Center, Multivendor environment knee cartilage T2, and
patellar T1-rho demonstrated moderate to excellent reproducibility (1).
Similarly phantom measurements over 8 years in the Osteoarthritis
Initiative environment showed good reproducibility of T2 relaxation
times varying from 1.5 to 5.3% (2). Single center studies found good
reproducibilities for dGEMRIC while less consistent data is available for
some the newer techniques such as gagCEST and quantitative CT
arthrography. In vitro studies showed that T1rho, T2 and dGEMRIC
measurements correlated with histological assays of proteoglycan and
collagen as well as mechanical properties of cartilage (3, 4). Clinical
studies documented differences in T1rho, T2 and dGEMRIC measure-
ments between patients with early osteoarthritis and normal controlsand one recent study showed that T2 measurements predicted radio-
graphic onset of knee osteoarthritis in a longitudinal study from the OAI
(5). Longitudinal studies also showed that T2 measurements increased
over time in normal populations, and were sensitive to weight loss and
physical activity. Problems, however, have been found in using meas-
ures of cartilage composition in more advanced degenerative disease.
Conclusion: A number of imaging biomarkers of joint composition are
available, which have been validated and shown to have good repro-
ducibility. T1rho, T2 and dGEMRIC are currently the imaging bio-
markers, which are best established with most studies having been
performed using T2 relaxation time measurements.
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SOXC TRANSCRIPTION FACTORS IN SKELETOGENESIS AND
CARTILAGE DIFFERENTIATION
V. Lefebvre, P. Bhattaram. Cleveland Clinic Lerner Res. Inst., Cleveland, OH,
USA
The healthy development and adult maintenance of the various struc-
tures that make up our skeleton rely on tight coordination of multiple
events. These events include cell fate decisions made by multipotent
mesenchymal progenitor/stem cells and differentiated cell types to
either survive or die, proliferate or growth arrest, migrate or settle, and
maintain stemness or differentiate. These decisions are controlled by
both cell-autonomous and non-cell-autonomous mechanisms, i.e.,
mechanisms dependent on intrinsic properties of cells and on external
cues, respectively. A pivotal decision made by every mesenchymal cell
of the onset of skeletogenesis is to be or not to be a chondrocyte. Sox9
forms with its functional partners, Sox5 and Sox6, a trio of transcription
factors required cell-autonomously for the commitment and differ-
entiation of mesenchymal cells into chondrocytes. In contrast, beta-
catenin is a structural protein and transcriptional co-activator required
to divert cells from the chondrocyte lineage and secure their differ-
entiation into non-chondrocytic cell types. These cell types include
prospective articular joint cells. Antagonism between Sox9 and beta-
catenin thus governs the proper design, development and articulation
of all cartilage templates of future bones. Although it acts cell-autono-
mously, beta-catenin is critically dependent upon canonical Wnt sig-
naling to be stable and thus capable of achieving its functions. This
pathway acts for a large part non-cell-autonomously. As of today, it
remains unknown whether articular progenitor cells and other non-
chondrocytic cell types use cell-autonomous mechanisms to stabilize
beta-catenin and thereby secure their lineage fate. We will show here
that we have newly identiﬁed a distinct trio of Sox proteins that has this
unique property. This trio is composed of Sox4, Sox11, and Sox12, the
three members of the SoxC group. Their inactivation in multipotent
mesenchymal progenitors in the mouse embryo results in a severe
skeletal dysplasia. Cartilage primordia form, but remain tiny and are
fused with each other due to a total absence of articular joints. The SoxC
genes are actively expressed inmesenchymal progenitor cells, including
presumptive joint cells. They have a key role in stabilizing beta-catenin
and thereby in repressing Sox9 expression and securing the non-
chondrocytic fate of the cells. Thus, the SoxC non-chondrocytic trio and
the Sox5/6/9 chondrogenic trio have opposite actions that are necessary
to decide the fate of mesenchymal progenitor/stem cells and thereby
develop a harmonious and fully functional skeleton, including articular
joints.
